Osimertinib / Osimertinib mesylate (osimertinib mesylate) — Uses, Dosage, Side Effects & Safety
Drug class: Cancer & Oncology
Overview
Osimertinib (osimertinib mesylate) is a targeted cancer medicine used to treat certain types of non-small cell lung cancer (NSCLC) that have specific mutations in the epidermal growth factor receptor (EGFR) gene. It is prescribed for adults whose cancer has spread (metastasized) or recurred after previous treatments. Osimertinib works by blocking the activity of mutated EGFR proteins on cancer cells, which helps slow or stop the growth of the tumor. It is especially effective in patients with EGFR T790M mutation-positive NSCLC and is also used as adjuvant therapy after tumor removal in early-stage EGFR-mutated NSCLC. Key points: Osimertinib is taken orally as a tablet, usually once daily. Patients should be aware of possible side effects, including diarrhea, rash, and risk of lung or heart problems. Regular monitoring is important during treatment.
Therapeutic uses
- Non-small cell lung cancer (NSCLC) with EGFR T790M mutation
- First-line treatment of metastatic EGFR-mutated non-small cell lung cancer (NSCLC)
- Adjuvant treatment of early-stage EGFR-mutated non-small cell lung cancer (NSCLC) after tumor resection
Common side effects
- Diarrhea
- Rash
- Dry skin
- Nail changes
- Stomatitis
- Interstitial lung disease
- Cardiomyopathy
- QT prolongation
Frequently Asked Questions about Osimertinib / Osimertinib mesylate
What is osimertinib used for?
Osimertinib is used to treat non-small cell lung cancer (NSCLC) with specific EGFR mutations, including T790M-positive and as adjuvant therapy after surgery.
How long do I need to take osimertinib?
The duration depends on your cancer type and response to treatment. Some patients take it until disease progression or unacceptable side effects occur. Your doctor will guide you.
Can osimertinib cure lung cancer?
Osimertinib is not a cure but can help control cancer, shrink tumors, and prolong survival in eligible patients.
What should I do if I experience severe diarrhea or rash?
Contact your healthcare provider promptly. They may recommend supportive care, dose adjustment, or temporary discontinuation.
Is osimertinib safe during pregnancy or breastfeeding?
No. Osimertinib can harm an unborn baby and is not recommended during pregnancy or breastfeeding. Use effective contraception during treatment and for a period after the last dose.
Can I take other medications with osimertinib?
Some medications can interact with osimertinib. Always inform your doctor about all medicines and supplements you are taking.
What monitoring is required while on osimertinib?
Regular blood tests, heart monitoring (ECG), and assessment for lung or eye symptoms are recommended during treatment.
Related Osimertinib / Osimertinib mesylate information
Educational information only. Always consult a qualified healthcare professional before starting, stopping, or changing any medication.